Company Filing History:
Years Active: 2011-2015
Title: Innovations of David MacLeod in Respiratory Treatment
Introduction
David MacLeod is an accomplished inventor based in Issaquah, WA (US). He has made significant contributions to the field of respiratory treatments, holding a total of 4 patents. His work focuses on innovative formulations that aim to improve the delivery and efficacy of medications for bacterial respiratory infections.
Latest Patents
One of MacLeod's latest patents is the "Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections." This patent describes a formulation that combines fosfomycin and tobramycin for delivery via aerosolization. The concentrated formulation is designed to inhibit susceptible bacteria effectively. The components are formulated separately in a dual ampoule, ensuring that when reconstituted, the pH remains between 4.5 and 8.0 or is available as a dry powder. The method of treatment involves delivering the aerosol with a mass median aerodynamic diameter predominantly between 1 to 5 micrometers, produced by a jet or ultrasonic nebulizer or a dry powder inhaler.
Career Highlights
Throughout his career, David MacLeod has worked with notable companies in the pharmaceutical industry, including Gilead Sciences, Inc. and Corus Pharma, Inc. His experience in these organizations has contributed to his expertise in developing innovative treatments for respiratory conditions.
Collaborations
MacLeod has collaborated with various professionals in his field, including his coworker William Baker. These collaborations have likely enhanced the development and refinement of his patented inventions.
Conclusion
David MacLeod's contributions to the field of respiratory treatment through his innovative patents demonstrate his commitment to improving patient care. His work continues to influence the development of effective therapies for bacterial respiratory infections.